SCM
SYRS

Superstring Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Superstring Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-37,789
Closed -$195K – 46
2024
Q2 		$195K Buy
+37,789
New +$195K 0.25% 38